Faecal calprotectin-based strategy for long-term monitoring of patients with Crohn's disease without or with mild endoscopic postoperative recurrence
Digestive and Liver Disease · 2025
DOI: 10.1016/j.dld.2024.11.028 ↗Kurz gefasst
Fachartikel in der Zeitschrift Digestive and Liver Disease, 2025. Verfasst von Míriam Mañosa und 8 weiteren Autor:innen. Beteiligte Einrichtung: Gastroentrology Department, Hospital Germans Trias i Pujol, 08916 Badalona, Catalonia, Spain; CIBEREHD, Madrid, Spain. Hauptthemen laut MEDLINE: Crohn Disease, Leukocyte L1 Antigen Complex, Feces. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: Spanish Working Group on Crohn's Disease and Ulcerative Colitis.
Abstract (Originalsprache)
BACKGROUND: Endoscopic evaluation 6-12 months after ileocolonic resection (ICR) in Crohn's disease (CD) is advised to assess the development of postoperative recurrence (POR) but no further recommendations are available for long-term monitoring if no POR is noticed. METHODS: Prospective, open-label, study including asymptomatic patients with CD and ICR in whom no POR was observed at the last endoscopic evaluation. Patients were followed-up for two years and ileocolonoscopy was performed by means of a faecal calprotectin (FC)-based strategy. RESULTS: Fifty-five patients were included. Six patients presented FC levels >250 µg/g in two consecutive measurements and severe endoscopic POR (RES i3-i4) was observed in four of them, whereas one had intermediate POR (RES i2) and one was diagnosed with colonic adenocarcinoma. Regarding the remaining patients, intermediate endoscopic POR was observed in 12 but none with severe endoscopic POR. The rate of severe endoscopic POR was 67 % among patients with two consecutive FC levels >250 µg/g. The area under the receiving operating curve for the prediction of severe endoscopic POR was 0.98 (p = 0.002). CONCLUSIONS: Serial measurement of FC is a suitable tool for the long-term monitoring of CD patients who do not develop early endoscopic POR and provides a suitable screening strategy for ileocolonoscopy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Gastroentrology Department, Hospital Germans Trias i Pujol, 08916 Badalona, Catalonia, Spain; CIBEREHD, Madrid, Spain.
- Gastroentrology Department, Hospital Germans Trias i Pujol, 08916 Badalona, Catalonia, Spain.
- Hospital de la Santa Creu i Sant Pau, Barcelona, Catalonia, Spain.
- Hospital de Bellvitge, L'Hospitalet del Llobregat, Catalonia, Spain.
- Gastroentrology Department, Hospital Germans Trias i Pujol, 08916 Badalona, Catalonia, Spain; CIBEREHD, Madrid, Spain; Departament de Medicina, Universitat Autònoma de Barcelona, Catalonia, Spain. Electronic address: ed…
Förderung
- Spanish Working Group on Crohn's Disease and Ulcerative Colitis
Zitieren
APA
Mañosa, M., Oller, B., Garcia-Planella, E., Guardiola, J., Cañete, F., González-Muñoza, C., Camps, B., Calafat, M., & Domènech, E. (2025). Faecal calprotectin-based strategy for long-term monitoring of patients with Crohn's disease without or with mild endoscopic postoperative recurrence. Digestive and Liver Disease. https://doi.org/10.1016/j.dld.2024.11.028
Vancouver
Mañosa M, Oller B, Garcia-Planella E, Guardiola J, Cañete F, González-Muñoza C, et al. Faecal calprotectin-based strategy for long-term monitoring of patients with Crohn's disease without or with mild endoscopic postoperative recurrence. Digestive and Liver Disease. 2025. doi:10.1016/j.dld.2024.11.028
BibTeX
@article{Maosa2025,
author = {Mañosa, Míriam and Oller, Blanca and Garcia-Planella, Esther and Guardiola, Jordi and Cañete, Fiorella and González-Muñoza, Carlos and Camps, Blau and Calafat, Margalida and Domènech, Eugeni},
title = {Faecal calprotectin-based strategy for long-term monitoring of patients with Crohn's disease without or with mild endoscopic postoperative recurrence},
journal = {Digestive and Liver Disease},
year = {2025},
doi = {10.1016/j.dld.2024.11.028}
}
EUVIMED